BKV LT-ag peptide LPLMRKAYL (HLA-B*0702)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
BKV LT-ag peptide LPLMRKAYL (HLA-B*0702)

BKV LT-ag peptide LPLMRKAYL (HLA-B*0702) is a single peptide for stimulation of T cells. The peptide from BK polyomavirus (BKV) large tumor antigen (LT-ag) is synthesized as it is presented by the MHC class I HLA-B*0702 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: LPLMRKAYL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-B*0702

Podobne produkty

Survivin peptide ELTLGEFLKL (HLA-A*0201)

Survivin peptide ELTLGEFLKL (HLA-A*0201)

IBA Lifescience
Więcej
CD4 Fab-TACS® Magnetic Microbead Starter Kit, human

CD4 Fab-TACS® Magnetic Microbead Starter Kit, human

IBA Lifescience
Więcej
CD8/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

CD8/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

IBA Lifescience
Więcej